Jackson Grant Investment Advisers’s Zimmer Biomet ZBH Stock Holding History

Jackson Grant Investment Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.33K	Hold	74	–	–	﹤0.01%	343
2026 Q1	$6.65K	Hold	74	–	–	﹤0.01%	328
2025 Q4	$6.61K	Hold	74	–	–	﹤0.01%	329
2025 Q3	$7.25K	Hold	74	–	–	﹤0.01%	316
2025 Q2	$6.71K	Hold	74	–	–	﹤0.01%	289
2025 Q1	$8.32K	Hold	74	–	–	﹤0.01%	272
2024 Q4	$7.77K	Hold	74	–	–	﹤0.01%	280
2024 Q3	$7.94K	Sell	74 -294	-80%	-$32.1K	﹤0.01%	282
2024 Q2	$39.9K	Hold	368	–	–	0.02%	193
2024 Q1	$48.5K	Hold	368	–	–	0.02%	174
2023 Q4	$44.7K	Hold	368	–	–	0.02%	179
2023 Q3	$41.3K	Hold	368	–	–	0.02%	175
2023 Q2	$53.5K	Hold	368	–	–	0.02%	164
2023 Q1	$47.5K	Hold	368	–	–	0.02%	188
2022 Q4	$46.9K	Hold	368	–	–	0.02%	183
2022 Q3	$38K	Hold	368	–	–	0.02%	205
2022 Q2	$39K	Sell	368 -234	-39%	-$27.8K	0.02%	209
2022 Q1	$77K	Buy	+602	New	+$72.6K	0.03%	166
2021 Q4	–	Sell	-620	Closed	-$88K	–	352
2021 Q3	$88K	Hold	620	–	–	0.04%	157
2021 Q2	$97K	Hold	620	–	–	0.04%	146
2021 Q1	$96K	Buy	620 +242	+64%	+$37.5K	0.04%	144
2020 Q4	$57K	Hold	378	–	–	0.03%	172
2020 Q3	$50K	Hold	378	–	–	0.03%	146
2020 Q2	$44K	Hold	378	–	–	0.03%	151
2020 Q1	$37K	Buy	378 +1	+0.3%	+$131	0.03%	149
2019 Q4	$55K	Hold	377	–	–	0.03%	145
2019 Q3	$50K	Hold	377	–	–	0.03%	149
2019 Q2	$43K	Hold	377	–	–	0.03%	156
2019 Q1	$47K	Hold	377	–	–	0.03%	147
2018 Q4	$38K	Hold	377	–	–	0.03%	157
2018 Q3	$48K	Sell	377 -29	-7%	-$3.45K	0.03%	147
2018 Q2	$44K	Hold	406	–	–	0.03%	157
2018 Q1	$43K	Hold	406	–	–	0.03%	157
2017 Q4	$48K	Hold	406	–	–	0.03%	150
2017 Q3	$46K	Hold	406	–	–	0.03%	148
2017 Q2	$51K	Buy	406 +103	+34%	+$12.2K	0.04%	130
2017 Q1	$36K	Hold	303	–	–	0.03%	136
2016 Q4	$30K	Hold	303	–	–	0.03%	144
2016 Q3	$38K	Hold	303	–	–	0.03%	126
2016 Q2	$35K	Hold	303	–	–	0.03%	128
2016 Q1	$31K	Hold	303	–	–	0.03%	122
2015 Q4	$30K	Buy	+303	New	+$29.6K	0.03%	126

Other funds holding ZBH

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

CapitalatWork SA Auderghem $3.99B AUM

MPMG

Minneapolis Portfolio Management Group Wayzata, Minnesota $1.06B AUM 63.37% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Jackson Grant Investment Advisers's ZBH Position: Q2 2026 in Review

Jackson Grant Investment Advisers held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 74 shares worth $6.33K. The position accounts for ﹤0.01% of the portfolio, ranked #343.

Jackson Grant Investment Advisers first reported a position in ZBH in Q4 2015 and has held it in 42 quarters since. The position peaked at $97K in Q2 2021. 347 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Jackson Grant Investment Advisers held 74 shares of Zimmer Biomet worth $6.33K as of Q2 2026.
Jackson Grant Investment Advisers left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #343 holding.
Jackson Grant Investment Advisers first reported a position in Zimmer Biomet in Q4 2015 and has held it in 42 quarters since.
Jackson Grant Investment Advisers's Zimmer Biomet position peaked at $97K in Q2 2021.
347 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.